Penserra Capital Management LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 966,654 shares of the company’s stock, valued at approximately $15,901,000.
Several other hedge funds have also recently added to or reduced their stakes in the company. Fountainhead AM LLC lifted its stake in BlackRock Capital Allocation Term Trust by 2.1% during the third quarter. Fountainhead AM LLC now owns 53,570 shares of the company’s stock worth $881,000 after purchasing an additional 1,095 shares during the last quarter. Prospera Financial Services Inc lifted its stake in shares of BlackRock Capital Allocation Term Trust by 5.0% in the 3rd quarter. Prospera Financial Services Inc now owns 23,693 shares of the company’s stock valued at $390,000 after acquiring an additional 1,137 shares during the last quarter. Blue Bell Private Wealth Management LLC lifted its stake in shares of BlackRock Capital Allocation Term Trust by 4.0% in the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company’s stock valued at $1,718,000 after acquiring an additional 4,059 shares during the last quarter. Transcend Capital Advisors LLC lifted its stake in shares of BlackRock Capital Allocation Term Trust by 7.3% in the 2nd quarter. Transcend Capital Advisors LLC now owns 65,207 shares of the company’s stock valued at $1,070,000 after acquiring an additional 4,435 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust by 4.3% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock valued at $2,186,000 after acquiring an additional 5,438 shares during the last quarter. Institutional investors own 36.12% of the company’s stock.
Insider Activity
In related news, major shareholder Saba Capital Management, L.P. sold 28,670 shares of the business’s stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $16.27, for a total transaction of $466,460.90. Following the transaction, the insider now owns 14,888,870 shares in the company, valued at $242,241,914.90. The trade was a 0.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders sold 723,927 shares of company stock valued at $11,925,047.
BlackRock Capital Allocation Term Trust Price Performance
BlackRock Capital Allocation Term Trust Increases Dividend
The business also recently announced a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a $0.2885 dividend. This represents a $3.46 dividend on an annualized basis and a dividend yield of 21.49%. The ex-dividend date of this dividend is Friday, November 15th. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10.
About BlackRock Capital Allocation Term Trust
–
Featured Articles
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Industrial Products Stocks Investing
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 11/18 – 11/22
- 3 Stocks to Consider Buying in October
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.